FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964241796> ?p ?o ?g. }

• W1964241796 endingPage "4158" @default.
• W1964241796 startingPage "4150" @default.
• W1964241796 abstract "B-cell chronic lymphocytic leukemia (CLL), an incurable leukemia, is characterized by defective apoptosis. We found that the SET oncoprotein, a potent inhibitor of the protein phosphatase 2A (PP2A) tumor suppressor, is overexpressed in primary CLL cells and B-cell non-Hodgkin lymphoma (NHL) cell line cells. In CLL, increased levels of SET correlated significantly with disease severity (shorter time to treatment and overall survival). We developed SET antagonist peptides that bound SET, increased cellular PP2A activity, decreased Mcl-1 expression, and displayed selective cytotoxicity for CLL and NHL cells in vitro. In addition, shRNA for SET was cytotoxic for NHL cells in vitro. The SET antagonist peptide COG449 inhibited growth of NHL tumor xenografts in mice. These data demonstrate that SET is a new treatment target in B-cell malignancies and that SET antagonists represent novel agents for treatment of CLL and NHL." @default.
• W1964241796 created "2016-06-24" @default.
• W1964241796 creator A5000594249 @default.
• W1964241796 creator A5007388681 @default.
• W1964241796 creator A5012711544 @default.
• W1964241796 creator A5017083278 @default.
• W1964241796 creator A5017933250 @default.
• W1964241796 creator A5018681392 @default.
• W1964241796 creator A5023416614 @default.
• W1964241796 creator A5031621433 @default.
• W1964241796 creator A5036101212 @default.
• W1964241796 creator A5049055623 @default.
• W1964241796 creator A5056470372 @default.
• W1964241796 creator A5056482233 @default.
• W1964241796 creator A5065233200 @default.
• W1964241796 creator A5068180883 @default.
• W1964241796 creator A5075225618 @default.
• W1964241796 creator A5078351605 @default.
• W1964241796 date "2011-10-13" @default.
• W1964241796 modified "2023-10-14" @default.
• W1964241796 title "SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target" @default.
• W1964241796 cites W180295822 @default.
• W1964241796 cites W1876581925 @default.
• W1964241796 cites W1969128566 @default.
• W1964241796 cites W1971212979 @default.
• W1964241796 cites W1975748957 @default.
• W1964241796 cites W1981076681 @default.
• W1964241796 cites W1981083415 @default.
• W1964241796 cites W1983579522 @default.
• W1964241796 cites W1997682598 @default.
• W1964241796 cites W2013222719 @default.
• W1964241796 cites W2020085126 @default.
• W1964241796 cites W2021359328 @default.
• W1964241796 cites W2025057435 @default.
• W1964241796 cites W2025309900 @default.
• W1964241796 cites W2025513910 @default.
• W1964241796 cites W2029544039 @default.
• W1964241796 cites W2032437577 @default.
• W1964241796 cites W2036758696 @default.
• W1964241796 cites W2038800779 @default.
• W1964241796 cites W2039775874 @default.
• W1964241796 cites W2040117983 @default.
• W1964241796 cites W2043203717 @default.
• W1964241796 cites W2045852899 @default.
• W1964241796 cites W2049090395 @default.
• W1964241796 cites W2054177883 @default.
• W1964241796 cites W2061243113 @default.
• W1964241796 cites W2076690627 @default.
• W1964241796 cites W2077697175 @default.
• W1964241796 cites W2078747147 @default.
• W1964241796 cites W2081680109 @default.
• W1964241796 cites W2086425912 @default.
• W1964241796 cites W2099348990 @default.
• W1964241796 cites W2100212868 @default.
• W1964241796 cites W2100665941 @default.
• W1964241796 cites W2103377960 @default.
• W1964241796 cites W2106461522 @default.
• W1964241796 cites W2121396722 @default.
• W1964241796 cites W2123122199 @default.
• W1964241796 cites W2124193450 @default.
• W1964241796 cites W2137336691 @default.
• W1964241796 cites W2142099365 @default.
• W1964241796 cites W2152876030 @default.
• W1964241796 cites W2165928290 @default.
• W1964241796 cites W2168875502 @default.
• W1964241796 cites W2221262359 @default.
• W1964241796 cites W2318933236 @default.
• W1964241796 cites W2322292515 @default.
• W1964241796 cites W2323490326 @default.
• W1964241796 doi "https://doi.org/10.1182/blood-2011-04-351072" @default.
• W1964241796 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3204732" @default.
• W1964241796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21844565" @default.
• W1964241796 hasPublicationYear "2011" @default.
• W1964241796 type Work @default.
• W1964241796 sameAs 1964241796 @default.
• W1964241796 citedByCount "104" @default.
• W1964241796 countsByYear W19642417962012 @default.
• W1964241796 countsByYear W19642417962013 @default.
• W1964241796 countsByYear W19642417962014 @default.
• W1964241796 countsByYear W19642417962015 @default.
• W1964241796 countsByYear W19642417962016 @default.
• W1964241796 countsByYear W19642417962017 @default.
• W1964241796 countsByYear W19642417962018 @default.
• W1964241796 countsByYear W19642417962019 @default.
• W1964241796 countsByYear W19642417962020 @default.
• W1964241796 countsByYear W19642417962021 @default.
• W1964241796 countsByYear W19642417962022 @default.
• W1964241796 countsByYear W19642417962023 @default.
• W1964241796 crossrefType "journal-article" @default.
• W1964241796 hasAuthorship W1964241796A5000594249 @default.
• W1964241796 hasAuthorship W1964241796A5007388681 @default.
• W1964241796 hasAuthorship W1964241796A5012711544 @default.
• W1964241796 hasAuthorship W1964241796A5017083278 @default.
• W1964241796 hasAuthorship W1964241796A5017933250 @default.
• W1964241796 hasAuthorship W1964241796A5018681392 @default.
• W1964241796 hasAuthorship W1964241796A5023416614 @default.
• W1964241796 hasAuthorship W1964241796A5031621433 @default.
• W1964241796 hasAuthorship W1964241796A5036101212 @default.

• next